Next-generation precision medicine for targeting recombination-deficient cancers
Ended Project Grant Awarded Last action
- Award ID
- R41CA239983
- Recipient
-
Recombination Therapeutics LLC UEI JLYJMA2WFYE3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $298,959
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Place of performance
- Pennsylvania, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $298,959 |
Quick answers
Who received award R41CA239983?
R41CA239983 was awarded to Recombination Therapeutics LLC by National Cancer Institute (National Institutes of Health) on March 10, 2020.
How much is award R41CA239983 worth?
$298,959 has been obligated on R41CA239983.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award